CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
13 hedge funds and large institutions have $7.69M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
18% more funds holding
Funds holding: 11 → 13 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less capital invested
Capital invested by funds: $10M → $7.69M (-$2.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$182K |
| 2 |
SIM
Spark Investment Management
New York
|
+$25.7K |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$19.8K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$7.84K |
| 5 |
MA
MUFG Americas
New York
|
+$2.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$642K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$129K |
| 3 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Caxton Corporation
Princeton,
New Jersey
| $5.68M | – | – | – |
|
|
OM
2
Opaleye Management
Boston,
Massachusetts
| $1.02M | +$182K | +66,598 | +20% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $568K | – | – | – |
|
4
California Public Employees Retirement System
Sacramento,
California
| $222K | – | – | – |
|
|
ACI
5
Alpha Cubed Investments
Irvine,
California
| $81K | – | – | – |
|
|
CPA
6
Cowen Prime Advisors
New York
| $49K | +$19.8K | +7,250 | +60% |
|
|
SIM
7
Spark Investment Management
New York
| $49K | +$25.7K | +9,400 | +90% |
|
|
BIM
8
BlackRock Investment Management
Wilmington,
Delaware
| $7K | +$7.84K | +2,865 | New |
|
|
9
Bank of America
Charlotte,
North Carolina
| $4K | -$129K | -46,992 | -97% |
|
|
MA
10
MUFG Americas
New York
| $3K | +$2.71K | +990 | New |
|
|
U
11
UBS
Zurich,
Switzerland
| $2K | +$2.35K | +860 | New |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| $271 | -$642K | -234,495 | -69% |
|
|
HLA
13
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
| – | -$51K | -17,280 | Closed |
|
CPXX Hedge Fund Activity: Q3 2014 in Review
13 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q3 2014, worth a combined $7.69M — down 23% from $10M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPXX positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Opaleye Management, adding an estimated $182K. The largest seller was Sabby Management, cutting an estimated $642K.
- 13 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q3 2014, up from 11 in Q2 2014.
- Funds reported $7.69M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q3 2014, down 23% quarter-over-quarter.
- 3 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q3 2014 and 1 closed out, a net change of +2 holders.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q3 2014 was Opaleye Management, an estimated $182K added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q3 2014 was Sabby Management, an estimated $642K sold.
Based on aggregated 13F filings for Q3 2014.